Gossamer Bio
Price & Volume
Stats
See moreOpen | $9.52 |
Previous Close | $9.28 |
Day Range | $9.52-$9.85 |
52W Range | $8.29-$309.60 |
Market Cap | $57.7M |
Shares Short | 1M |
Financials
See moreRevenue (12 Mos) | $53.2M |
Revenue Growth (YoY) | -19.6% |
Gross Profit (12 Mos) | $53.2M |
Diluted EPS | -$48.07 |
News
See moreYahoo Finance • 22 days ago
Adobe downgraded, VF Corp. upgraded: Wall Street's top analyst calls
Yahoo Finance • 2 months ago
Assessment of the Pulmonary Arterial Hypertension (PAH) Market 2026-2036 Featuring United Therapeutics, Mochida Pharmaceutical, Johnson & Johnson, Merck, and Gossamer Bio
Yahoo Finance • 2 months ago
Gossamer Bio announces $250m in funding to advance seralutinib
Yahoo Finance • 2 months ago
Sector Update: Healthcare Stocks Advance in Afternoon Trading
About
CEO | Mr. Faheem Hasnain |
CFO | Mr. Bryan Giraudo |
Address | 3115 Merryfield Row, San Diego, CA, United States, 92121 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 161 |